Related Experiment Video

Updated: Mar 3, 2026

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

1.3K

Galectin-3 in acute coronary syndrome

Luisa Agnello1, Giulia Bivona1, Bruna Lo Sasso1

  • 1Sezione Biochimica Clinica e Medicina Molecolare Clinica, Dipartimento di Biopatologia e Biotecnologie Mediche, Università degli Studi di Palermo, Italy.

Clinical Biochemistry
|May 1, 2017
PubMed

Insights

Galectin-3 shows promise as a prognostic biomarker for acute coronary syndrome (ACS) patients. Studies indicate Gal-3 independently predicts mortality and heart failure (HF) after ACS events.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Research

Background:

  • Acute coronary syndrome (ACS) is a leading cause of global hospitalizations.
  • Biomarkers are crucial for diagnosing, stratifying risk, and predicting prognosis in cardiovascular diseases like ACS.
  • Troponin is the current gold standard for ACS diagnosis, but research seeks additional prognostic markers.

Purpose of the Study:

  • To review existing literature on the prognostic role of Galectin-3 (Gal-3) in patients with ACS.
  • To evaluate Gal-3 as a potential predictive biomarker for adverse outcomes following ACS.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of data on Gal-3's association with mortality and heart failure (HF) in ACS patients.

Main Results:

  • Galectin-3 (Gal-3) has emerged as a significant prognostic marker in the context of ACS.
  • Experimental and clinical data suggest Gal-3 plays a key role in inflammation and fibrosis.
  • Gal-3 has been identified as an independent predictor of all-cause mortality, cardiovascular death, and HF occurrence post-ACS.

Conclusions:

  • Galectin-3 is a promising prognostic biomarker for patients experiencing acute coronary syndrome.
  • Gal-3's involvement in inflammatory and fibrotic pathways supports its predictive value for adverse cardiovascular outcomes.
  • Further investigation into Gal-3 may enhance risk stratification and management strategies for ACS patients.

Keywords:
AMIAcute coronary syndromeGalectin-3Heart failureMyocardial infarctionPrognosis

More Related Videos

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads08:48

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Published on: December 9, 2020

2.5K
Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy06:38

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

1.3K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
345
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
570
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
350
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
485
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K